Any 0 3 0 3 O
disease 4 11 4 11 O
, 11 12 11 12 O
diagnosis 13 22 13 22 O
, 22 23 22 23 O
or 24 26 24 26 O
condition 27 36 27 36 O
( 37 38 37 38 O
medical 38 45 38 45 O
or 46 48 46 48 O
surgical 49 57 49 57 O
) 57 58 57 58 O
that 59 63 59 63 O
, 63 64 63 64 O
in 65 67 65 67 O
the 68 71 68 71 O
opinion 72 79 72 79 O
of 80 82 80 82 O
the 83 86 83 86 O
Principal 87 96 87 96 O
Investigator 97 109 97 109 O
, 109 110 109 110 O
would 111 116 111 116 O
place 117 122 117 122 O
the 123 126 123 126 O
subject 127 134 127 134 O
at 135 137 135 137 O
increased 138 147 138 147 O
risk 148 152 148 152 O
( 153 154 153 154 O
active 154 160 154 160 O
gynecologic 161 172 161 172 B-chronic_disease
disease 173 180 173 180 I-chronic_disease
in 181 183 181 183 O
which 184 189 184 189 O
increased 190 199 190 199 O
tone 200 204 200 204 O
would 205 210 205 210 O
be 211 213 211 213 O
detrimental 214 225 214 225 O
e.g. 226 230 226 230 O
, 230 231 230 231 O
uterine 232 239 232 239 B-chronic_disease
fibroids 240 248 240 248 I-chronic_disease
with 249 253 249 253 O
ongoing 254 261 254 261 O
bleeding 262 270 262 270 O
) 270 271 270 271 O
, 271 272 271 272 O
compromise 273 283 273 283 O
the 284 287 284 287 O
subject 288 295 288 295 O
's 295 297 295 297 O
compliance 298 308 298 308 O
with 309 313 309 313 O
study 314 319 314 319 O
procedures 320 330 320 330 O
, 330 331 330 331 O
or 332 334 332 334 O
compromise 335 345 335 345 O
the 346 349 346 349 O
quality 350 357 350 357 O
of 358 360 358 360 O
the 361 364 361 364 O
dat 365 368 365 368 O

Neuropathic 0 11 369 380 B-chronic_disease
pain 12 16 381 385 I-chronic_disease
for 17 20 386 389 O
> 21 22 390 391 O
6 23 24 392 393 B-lower_bound
months 25 31 394 400 I-lower_bound

Pregnancy 0 9 401 410 B-pregnancy

Weight 0 6 411 417 B-clinical_variable
< 7 8 418 419 O
or 9 11 420 422 O
equal 12 17 423 428 O
to 18 20 429 431 O
240 21 24 432 435 B-upper_bound
pounds 25 31 436 442 I-upper_bound

chronic 0 7 443 450 O
intrathecal 8 19 451 462 B-treatment
drug 20 24 463 467 I-treatment
therapy 25 32 468 475 I-treatment

oral 0 4 476 480 B-treatment
opioid 5 11 481 487 I-treatment
treatment 12 21 488 497 I-treatment
for 22 25 498 501 O
> 26 27 502 503 O
3 28 29 504 505 B-lower_bound
months 30 36 506 512 I-lower_bound
at 37 39 513 515 O
a 40 41 516 517 O
current 42 49 518 525 O
dose 50 54 526 530 O
of 55 57 531 533 O
> 58 59 534 535 O
100 60 63 536 539 B-lower_bound
milligram 64 73 540 549 I-lower_bound
( 74 75 550 551 I-lower_bound
mg 75 77 551 553 I-lower_bound
) 77 78 553 554 I-lower_bound
morphine 79 87 555 563 B-treatment
per 88 91 564 567 O
day 92 95 568 571 O
or 96 98 572 574 O
equivalent 99 109 575 585 O

significant 0 11 586 597 O
reaction 12 20 598 606 O
to 21 23 607 609 O
any 24 27 610 613 O
ingredient 28 38 614 624 O
of 39 41 625 627 O
the 42 45 628 631 O
study 46 51 632 637 B-allergy_name
drug 52 56 638 642 I-allergy_name
or 57 59 643 645 O
lidocaine 60 69 646 655 B-allergy_name

